A novel LASSO‐derived prognostic model predicting survival for non‐small cell lung cancer patients with M1a diseases

INTRODUCTION: The current American Joint Committee on Cancer (AJCC) M1a staging of non‐small cell lung cancer (NSCLC) encompasses a wide disease spectrum, showing diverse prognosis. METHODS: Patients who diagnosed in an earlier period formed the training cohort, and those who diagnosed thereafter fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongchao, Huang, Chen, Ge, Huiqing, Chen, Qianshun, Chen, Jing, Li, Yuqiang, Chen, Haiyong, Luo, Shiyin, Zhao, Lilan, Xu, Xunyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921928/
https://www.ncbi.nlm.nih.gov/pubmed/35128839
http://dx.doi.org/10.1002/cam4.4560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921928/
https://www.ncbi.nlm.nih.gov/pubmed/35128839
http://dx.doi.org/10.1002/cam4.4560

Ejemplares similares